We're hardwired to crave fat and sugar. This drive for calorie-dense foods is a big part of how our ancient ancestors ...

Dr. Alexandra Sowa highlights the risks of microdosing Ozempic for benefits other than treating diabetes and losing weight.

Do you think she's on Ozempic?' asked one, tilting her head conspiratorially towards a stick-like woman a few tables across, who was pushing her spinach salad around her plate. 'If I was rich ...

Ozempic (semaglutide) is a brand-name drug prescribed to treat certain conditions, such as type 2 diabetes. Ozempic has interactions with some other drugs, such as insulin, and certain supplements ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is ...

Novo Nordisk (NYSE:NVO) just scored a game-changing FDA approval for Ozempic, expanding its use beyond diabetes to tackle chronic kidney disease and cardiovascular risks. The move solidifies ...

The operation in New York City began early Tuesday morning. Video shows agents with ICE, the Department of Homeland Security, the Bureau of Alcohol, Tobacco, Firearms and Explosives, and the Drug ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...

More well-known as ICE, the agency stated Monday that they were, "conducting enhanced targeted operations today in Chicago to enforce U.S. immigration law and preserve public safety and national ...

US FDA Approves Novo Nordisk's Ozempic to Cut Risk of Diabetic Kidney Disease Progression (Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and ...